Globally, the market for antidepressant drugs mask has been growing at a swift pace on the back of rising prevalence mental disorders, rising healthcare awareness and rising disposable incomes. Apart from these factors, rising healthcare facilities, increasing number of psychiatrist as well as surging number of hospital and clinics and burgeoning growth in Asia Pacific market is impelling growth in the market.

A comprehensive research report that analyses the antidepressant drugs market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents, the report also assesses the sales of antidepressant drugs by sales channels - Hospital & Clinics, Retail Pharmacies, Others.

A research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antidepressant Drugs Market By Region (North America, Europe, Asia Pacific and Rest of the world) and By Country (U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia) for the historical period of 2013-2017 and forecast period of 2018-2023.

According to Azoth Analytics research report “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)”, the global market is projected to display a robust growth represented by a CAGR of 3.12% during 2018 – 2023.

The Selective Serotonin Reuptake Inhibitors (SSRIs) drug class has witnessed growth at a noteworthy rate over the past few years and in the forecast period on account of rising health awareness related to mental disorders particularly in developing countries including China, India, etc., rising healthcare expenditure as well as rising disposable incomes. Amongst the regions, North America accounts for the largest regional share in the global antidepressant drugs in 2017.

The report titled “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)” has covered and analysed the potential of Global Antidepressant Drugs Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global antidepressant drugs market. Additionally, the report also highlights market entry strategies for various companies across the globe.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antidepressant Drugs Market: Analysis By Drugs Class (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents), By Sales Channels (Hospital & Clinics, Retail Pharmacies, Others) for the Regions (North America, Europe, Asia Pacific and Rest of the world) and for Countries (U.S., Canada , Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia).